Introduction: Chemotherapy-induced nausea and vomiting (CINV) is one of the most important worries ofcancer patients. Although not life-threatening, it has a great negative impact on quality of life (QOL).
Objective:The aim of this study was to determine the impact of CINV (i.e., acute and delayed) on breast cancer patientsQOL and to discern opinions related with antiemetic guidelines used dependent on the three main races inMalaysia (Malay, Chinese, Indian).
Methods: In this longitudinal prospective observational study, 158 breastcancer patients treated with chemotherapy were interviewed and valid questionnaires (MANE and ONEM) wereused to report the impact of CINV on their QOL within the first 24 hours and after 3 to 5 days of chemotherapytreatment.
Results: The main result was that delayed CINV has an impact on QOL greater than acute CINV. Theimpact of nausea was reportedly higher than that of vomiting. Also differences in race i.e., genetic polymorphisms(pharmacogenomics) influenced the utility of antiemetic treatments and patients opinions.
Conclusion: Based onthe results of our study a new guideline for antiemetic treatment should be used to reduce the impact of CINVon QOL, taking into account variation in genetic polymorphisms among the three races in Malaysia.